2023
DOI: 10.1016/j.jddst.2022.103995
|View full text |Cite
|
Sign up to set email alerts
|

Hybrid protein-polymer nanoparticles based on P(NVCL-co-DMAEMA) loaded with cisplatin as a potential anti-cancer agent

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
7
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(7 citation statements)
references
References 71 publications
0
7
0
Order By: Relevance
“…In 2022, Viana et al [ 211 ] published the fabrication of protein–polymer conjugated NPs of BSA and thermoresponsive copolymer of N-vinylcaprolactam (NVCL) and N,N-dimethylaminoethyl methacrylate (DMAEMA) with excellent properties to be used in the biomedical field such as drug delivery, and also showing antitumor properties. BSA-P(NVCL-co-DMAEMA) nanoparticles were produced by controlled radical polymerization (CRP) employing grafting-from in aqueous medium using Cu(0)-mediated radical polymerization.…”
Section: Current Chemical and Physical Modifications Of Nanomembranes...mentioning
confidence: 99%
“…In 2022, Viana et al [ 211 ] published the fabrication of protein–polymer conjugated NPs of BSA and thermoresponsive copolymer of N-vinylcaprolactam (NVCL) and N,N-dimethylaminoethyl methacrylate (DMAEMA) with excellent properties to be used in the biomedical field such as drug delivery, and also showing antitumor properties. BSA-P(NVCL-co-DMAEMA) nanoparticles were produced by controlled radical polymerization (CRP) employing grafting-from in aqueous medium using Cu(0)-mediated radical polymerization.…”
Section: Current Chemical and Physical Modifications Of Nanomembranes...mentioning
confidence: 99%
“…Over the last decade, the use of nanocarriers to minimize the side effects of available anticancer drugs and improve therapeutic effect has attracted significant attention. Various nanostructures have been explored as drug carriers, such as liposomes, polymeric nanoparticles, nanogels, mesoporous silica nanoparticles, carbon nanotubes, quantum dots, and magnetic nanoparticles 5–7 . Magnetic nanoparticles (MNs), especially iron oxide nanoparticles (IONPs) have excellent hydrophilicity, biocompatibility, small particle size, low toxicity and unique superparamagnetic properties and have been most widely investigated in the medical fields, such as drug delivery, hyperthermia treatment, and magnetic resonance imaging 8,9 .…”
Section: Introductionmentioning
confidence: 99%
“…Various nanostructures have been explored as drug carriers, such as liposomes, polymeric nanoparticles, nanogels, mesoporous silica nanoparticles, carbon nanotubes, quantum dots, and magnetic nanoparticles. [5][6][7] Magnetic nanoparticles (MNs), especially iron oxide nanoparticles (IONPs) have excellent hydrophilicity, biocompatibility, small particle size, low toxicity and unique superparamagnetic properties and have been most widely investigated in the medical fields, such as drug delivery, hyperthermia treatment, and magnetic resonance imaging. 8,9 However, due to the large surface-to-volume ratio and magnetic dipole-dipole interaction, IONPs tend to agglomerate, which leads to a significant reduction of their circulation time in the body.…”
mentioning
confidence: 99%
“…Among the currently known cationic polymers used for gene delivery, there are a small number of polymers, such as chitosan, poly(2-(N, N -dimethylamino)ethyl methacrylate), polyethyleneimine, which provide effective targeted delivery of DNA plasmids and are, at the same time, substances that affect the cell membrane [ 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 ]. It should be noted that cationic polyelectrolytes with a high charge density also have high cytotoxicity, which can be reduced by introducing polyethylene glycol (polyethylene oxide—PEO), which has good water solubility and biocompatibility, into their composition.…”
Section: Introductionmentioning
confidence: 99%